Fresenius Medical Care AG & Co. KGaA
FMS · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $19,335,909 | $19,453,617 | $19,398,017 | $17,618,685 |
| % Growth | -0.6% | 0.3% | 10.1% | – |
| Cost of Goods Sold | $14,579,257 | $14,528,612 | $14,504,328 | $12,845,656 |
| Gross Profit | $4,756,652 | $4,925,005 | $4,893,689 | $4,773,029 |
| % Margin | 24.6% | 25.3% | 25.2% | 27.1% |
| R&D Expenses | $183,493 | $231,970 | $228,624 | $220,782 |
| G&A Expenses | $2,366,287 | $2,388,375 | $2,369,494 | $0 |
| SG&A Expenses | $3,142,819 | $3,196,336 | $3,170,370 | $2,772,831 |
| Sales & Mktg Exp. | $776,532 | $807,961 | $800,876 | $0 |
| Other Operating Expenses | $37,945 | $127,261 | -$17,060 | -$72,874 |
| Operating Expenses | $3,364,257 | $3,555,567 | $3,381,934 | $2,920,739 |
| Operating Income | $1,392,395 | $1,369,438 | $1,511,755 | $1,852,290 |
| % Margin | 7.2% | 7% | 7.8% | 10.5% |
| Other Income/Exp. Net | -$335,469 | -$336,423 | -$292,476 | -$280,429 |
| Pre-Tax Income | $1,056,926 | $1,033,015 | $1,219,279 | $1,571,861 |
| Tax Expense | $316,056 | $300,557 | $324,954 | $352,833 |
| Net Income | $537,913 | $498,997 | $673,405 | $969,308 |
| % Margin | 2.8% | 2.6% | 3.5% | 5.5% |
| EPS | 0.92 | 0.85 | 0.57 | 0.83 |
| % Growth | 8.2% | 49.1% | -31.3% | – |
| EPS Diluted | 0.92 | 0.85 | 0.57 | 0.83 |
| Weighted Avg Shares Out | 587,884 | 587,056 | 1,172,986 | 1,171,779 |
| Weighted Avg Shares Out Dil | 586,827 | 586,827 | 1,172,986 | 1,171,779 |
| Supplemental Information | – | – | – | – |
| Interest Income | $71,575 | $88,217 | $67,663 | $73,170 |
| Interest Expense | $407,044 | $424,640 | $360,139 | $353,599 |
| Depreciation & Amortization | $1,742,257 | $1,751,971 | $1,838,363 | $1,623,676 |
| EBITDA | $3,206,227 | $3,209,626 | $3,417,781 | $3,549,136 |
| % Margin | 16.6% | 16.5% | 17.6% | 20.1% |